Indeed, mTORC1 signaling was activated by MFN2 OE and inhibited after MFN2 or OPA1 suppression, while ROS depletion by MTTP inhibited mTORC1 signaling in AML cells (Supplementary Fig. S4E-J). The gene discussed is OPA1; the disease is acute myeloid leukemia.